Literature DB >> 12482429

Synthesis of non-competitive inhibitors of sphingomyelinases with significant activity.

Tsutomu Yokomatsu1, Tetsuo Murano, Takeshi Akiyama, Junichi Koizumi, Shiroshi Shibuya, Yoshiaki Tsuji, Shinji Soeda, Hiroshi Shimeno.   

Abstract

A series of short-chain analogues of N-palmitoylsphingosine-1-phosphate, modified by replacement of the phosphate and the long alkenyl side chain with hydrolytically stable difluoromethylene phosphonate and phenyl, respectively, were prepared to study the structure-activity relationship for inhibition of sphingomyelinase. The study revealed that inhibition is highly dependent upon the stereochemistry of the asymmetric centers of the acylamino moiety, and resulted in identification of a non-competitive inhibitor with the same level of inhibitory activity of schyphostatin, the most potent of the few known small molecular inhibitors of sphingomyelinase.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12482429     DOI: 10.1016/s0960-894x(02)00888-0

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  8 in total

Review 1.  Small Molecule Inhibitors Targeting Biosynthesis of Ceramide, the Central Hub of the Sphingolipid Network.

Authors:  Jan Skácel; Barbara S Slusher; Takashi Tsukamoto
Journal:  J Med Chem       Date:  2021-01-04       Impact factor: 7.446

2.  Acid sphingomyelinase inhibition suppresses lipopolysaccharide-mediated release of inflammatory cytokines from macrophages and protects against disease pathology in dextran sulphate sodium-induced colitis in mice.

Authors:  Akira Sakata; Takashi Ochiai; Hiroshi Shimeno; Sadao Hikishima; Tsutomu Yokomatsu; Shiroshi Shibuya; Akihisa Toda; Reiko Eyanagi; Shinji Soeda
Journal:  Immunology       Date:  2007-04-23       Impact factor: 7.397

3.  Reductive activity of free and immobilized cells of cyanobacteria toward oxophosphonates-comparative study.

Authors:  Monika Górak; Ewa Żymańczyk-Duda
Journal:  J Appl Phycol       Date:  2016-09-15       Impact factor: 3.215

4.  Synthesis of syn-gamma-amino-beta-hydroxyphosphonates by reduction of beta-ketophosphonates derived from L-proline and L-serine.

Authors:  Mario Ordóñez; Selene Lagunas-Rivera; Emanuel Hernández-Núñez; Victoria Labastida-Galván
Journal:  Molecules       Date:  2010-03-04       Impact factor: 4.411

5.  Targeting Loxosceles spider Sphingomyelinase D with small-molecule inhibitors as a potential therapeutic approach for loxoscelism.

Authors:  Priscila Hess Lopes; Mário T Murakami; Fernanda C V Portaro; Kerly Fernanda Mesquita Pasqualoto; Carmen van den Berg; Denise V Tambourgi
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

6.  Highly Diastereoselective Construction of Carbon- Heteroatom Quaternary Stereogenic Centers in the Synthesis of Analogs of Bioactive Compounds: From Monofluorinated Epoxyalkylphosphonates to α-Fluoro-, β-, or γ-Amino Alcohol Derivatives of Alkylphosphonates.

Authors:  Magdalena Rapp; Klaudia Margas-Musielak; Patrycja Kaczmarek; Agnieszka Witkowska; Tomasz Cytlak; Tomasz Siodła; Henryk Koroniak
Journal:  Front Chem       Date:  2021-06-02       Impact factor: 5.221

Review 7.  Potential therapeutic target for aging and age-related neurodegenerative diseases: the role of acid sphingomyelinase.

Authors:  Min Hee Park; Hee Kyung Jin; Jae-Sung Bae
Journal:  Exp Mol Med       Date:  2020-03-13       Impact factor: 8.718

8.  Acid Sphingomyelinase Deficiency Ameliorates Farber Disease.

Authors:  Nadine Beckmann; Katrin Anne Becker; Stephanie Kadow; Fabian Schumacher; Melanie Kramer; Claudine Kühn; Walter J Schulz-Schaeffer; Michael J Edwards; Burkhard Kleuser; Erich Gulbins; Alexander Carpinteiro
Journal:  Int J Mol Sci       Date:  2019-12-11       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.